Litesitamet Tablet 50/1000 mg
Sitagliptin Hydrochloride Hydrate 56.7mg · Metformin Hydrochloride with Colloidal Anhydrous Silica 1010mg
Tablet · Prescription medication · Combination
Lites Pharm Tech Co., Ltd.
MFDS item code 202200487 · Approved 2022.01.28
Improves blood sugar control in type 2 diabetes
This medication is used in conjunction with diet and exercise therapy to help control blood sugar in patients with type 2 diabetes. It can be used alone, especially in cases where patients have not been treated with blood sugar control medications previously. This drug is also used when blood sugar control is difficult with either metformin or sitagliptin monotherapy, or when replacing the combination of both drugs. In addition, if there is no effect with combination therapy of metformin and sulfonylurea, or metformin and thiazolidinedione, this medication can be used in combination to enhance therapeutic effects. It also improves blood sugar control when used together with insulin and metformin in cases where blood sugar control is insufficient. Therefore, it is used as an effective adjunct in various therapeutic situations for blood sugar control.
This medication is typically taken twice daily with food, and the dosage is gradually increased to reduce gastrointestinal side effects caused by metformin. The initial dose is determined based on the patient's current treatment regimen. 1. For patients not treated with metformin: The initial dose is 50/500 mg of this medication taken twice daily, increasing to 50/1000 mg, one tablet each time.
This medication contains sitagliptin and metformin, which require caution during use. First, this medication may cause allergic reactions, so if symptoms like hives, rash, or difficulty breathing occur, discontinue use immediately and consult a physician. There is a risk of acute pancreatitis, which is inflammation of the pancreas, so be vigilant for symptoms like abdominal pain, nausea, and vomiting, and stop taking the medication right away if suspected. Moreover, this medication should not be administered to patients with severe renal impairment, acute heart failure, or myocardial infarction, and it should be temporarily stopped before and after surgeries or examinations using radioactive iodine contrast agents. It is advisable not to use it in pregnant or breastfeeding women or in children and adolescents under 18 years of age, as safety has not been established. Regular monitoring of renal function is necessary while on this medication, especially for the elderly or patients with weakened kidney function. Additionally, this medication may cause hypoglycemia, so blood sugar levels should be carefully monitored in cases of irregular meal patterns, vigorous exercise, or when taken with other blood sugar-lowering agents. Alcohol consumption may increase the risk of lactic acidosis, so excessive drinking should be avoided, and symptoms like malaise, muscle pain, respiratory distress, and abdominal pain should be reported to medical personnel immediately. During the course of this medication, rare side effects like severe joint pain or bullous pemphigoid may occur; if these symptoms occur, inform a doctor immediately. Finally, this medication may interact with various drugs, so if other medications are being taken, it is essential to consult with a physician or pharmacist, particularly when using drugs that might affect kidney function.
Not everyone experiences these, and they can vary from person to person.
This medication should be kept in a tightly closed container to prevent air or moisture from entering, and it is best stored at a temperature between 1°C and 30°C at room temperature. By doing so, the effectiveness of the medication can be maintained, and degradation can be prevented.
Brown oval film-coated tablet engraved with 751 on one side
30 tablets/box [(10 tablets/PTP x 3)]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Sitagliptin Hydrochloride Hydrate 56.7mg · Metformin Hydrochloride with Colloidal Anhydrous Silica 1010mg
Tablet · Prescription medication · Combination
Lites Pharm Tech Co., Ltd.
CombinationSitagliptin Hydrochloride Hydrate 56.7mg · Metformin Hydrochloride with Colloidal Anhydrous Silica 858.5mg
Tablet · Prescription medication · Combination
Daewon Pharmaceutical Co., Ltd.
CombinationSitagliptin Hydrochloride Hydrate 56.7mg · Metformin Hydrochloride with Colloidal Anhydrous Silica 1010mg
Tablet · Prescription medication · Combination
Daewon Pharmaceutical Co., Ltd.
CombinationSitagliptin Hydrochloride Hydrate 56.7mg · Metformin Hydrochloride with Colloidal Anhydrous Silica 505mg
Tablet · Prescription medication · Combination
Daewon Pharmaceutical Co., Ltd.
CombinationSitagliptin Hydrochloride Hydrate 56.7mg · Metformin Hydrochloride with Colloidal Anhydrous Silica 505mg
Tablet · Prescription medication · Combination
Samsung Pharmaceutical Co., Ltd.
CombinationSitagliptin Hydrochloride Hydrate 56.7mg · Metformin Hydrochloride with Colloidal Anhydrous Silica 858.5mg
Tablet · Prescription medication · Combination
Samsung Pharmaceutical Co., Ltd.
CombinationSitagliptin Hydrochloride Hydrate 56.7mg · Metformin Hydrochloride with Colloidal Anhydrous Silica 1010mg
Tablet · Prescription medication · Combination
Samsung Pharmaceutical Co., Ltd.
CombinationSitagliptin Hydrochloride Hydrate 56.7mg · Metformin Hydrochloride with Colloidal Anhydrous Silica 1010mg
Tablet · Prescription medication · Combination
Eden Pharma Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.